Baker Biotech Capital (GP), LLC Insider Trading $IDRA IDERA PHARMACEUTICALS, INC.
Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Biotech Capital (GP), LLC in IDERA PHARMACEUTICALS, INC.
Trading Symbol: IDRAIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Biotech Capital (GP), LLC: 10% Owner
Holdings: 209,110 shares
Current Value: $326,212
Latest Transaction: Jul 30 2008
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC in IDERA PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, IDRA, INCY, NRGN, PCYC, SGEN, VPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 30 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 14.93 | 9,839 | 146,906 | 209,110 | 218.9 K to 209.1 K (-4.49 %) |
Jul 30 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 14.87 | 2,952 | 43,904 | 218,949 | 221.9 K to 218.9 K (-1.33 %) |
Jul 25 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 15.01 | 9,224 | 138,468 | 221,901 | 231.1 K to 221.9 K (-3.99 %) |
Jul 25 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 15.02 | 15,374 | 230,933 | 231,125 | 246.5 K to 231.1 K (-6.24 %) |
Jul 25 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 14.86 | 9,839 | 146,198 | 246,499 | 256.3 K to 246.5 K (-3.84 %) |
Jul 21 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 14.80 | 18,449 | 273,045 | 256,338 | 274.8 K to 256.3 K (-6.71 %) |
Jul 16 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 15.24 | 8,579 | 130,754 | 274,787 | 283.4 K to 274.8 K (-3.03 %) |
Jul 01 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 14.51 | 4,920 | 71,406 | 283,366 | 288.3 K to 283.4 K (-1.71 %) |
Jul 01 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 14.99 | 12,606 | 188,998 | 288,286 | 300.9 K to 288.3 K (-4.19 %) |
Jul 01 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 15.41 | 165,874 | 2,556,118 | 300,892 | 466.8 K to 300.9 K (-35.54 %) |
Jan 14 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 13.00 | 215 | 2,796 | 466,766 | 467 K to 466.8 K (-0.05 %) |
Jan 09 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 13.00 | 1,107 | 14,392 | 466,981 | 468.1 K to 467 K (-0.24 %) |
Jan 09 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 13.00 | 31 | 403 | 468,088 | 468.1 K to 468.1 K (-0.01 %) |
Jan 09 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 13.00 | 31 | 403 | 468,119 | 468.2 K to 468.1 K (-0.01 %) |
Jan 04 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 13.14 | 5,380 | 70,709 | 468,150 | 473.5 K to 468.2 K (-1.14 %) |
Jan 04 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 13.29 | 5,166 | 68,668 | 473,530 | 478.7 K to 473.5 K (-1.08 %) |
Jan 04 2008 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.94 | 15,374 | 198,989 | 478,696 | 494.1 K to 478.7 K (-3.11 %) |
Dec 12 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.25 | 31 | 380 | 494,070 | 494.1 K to 494.1 K (-0.01 %) |
Dec 12 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.25 | 1,384 | 16,958 | 494,101 | 495.5 K to 494.1 K (-0.28 %) |
Dec 12 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.36 | 3,136 | 38,774 | 495,485 | 498.6 K to 495.5 K (-0.63 %) |
Dec 07 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.25 | 4,059 | 49,742 | 498,621 | 502.7 K to 498.6 K (-0.81 %) |
Dec 07 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.35 | 12,606 | 155,723 | 502,680 | 515.3 K to 502.7 K (-2.45 %) |
Dec 07 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.28 | 6,180 | 75,915 | 515,286 | 521.5 K to 515.3 K (-1.19 %) |
Dec 04 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.21 | 7,195 | 87,820 | 521,466 | 528.7 K to 521.5 K (-1.36 %) |
Dec 04 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.16 | 12,300 | 149,579 | 528,661 | 541 K to 528.7 K (-2.27 %) |
Dec 04 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.03 | 8,887 | 106,913 | 540,961 | 549.8 K to 541 K (-1.62 %) |
Nov 21 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 11.80 | 698 | 8,238 | 549,848 | 550.5 K to 549.8 K (-0.13 %) |
Nov 15 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 11.77 | 13,213 | 155,580 | 550,546 | 563.8 K to 550.5 K (-2.34 %) |
Nov 15 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.05 | 2,829 | 34,092 | 563,759 | 566.6 K to 563.8 K (-0.50 %) |
Nov 15 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.02 | 3,997 | 48,050 | 566,588 | 570.6 K to 566.6 K (-0.70 %) |
Nov 08 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.72 | 5,183 | 65,937 | 570,585 | 575.8 K to 570.6 K (-0.90 %) |
Nov 08 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.66 | 24,383 | 308,642 | 575,768 | 600.2 K to 575.8 K (-4.06 %) |
Nov 08 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.14 | 30,747 | 373,269 | 600,151 | 630.9 K to 600.2 K (-4.87 %) |
Nov 05 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.05 | 3,936 | 47,439 | 630,898 | 634.8 K to 630.9 K (-0.62 %) |
Nov 05 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 11.88 | 10,177 | 120,874 | 634,834 | 645 K to 634.8 K (-1.58 %) |
Nov 05 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 11.50 | 8,118 | 93,364 | 645,011 | 653.1 K to 645 K (-1.24 %) |
Oct 31 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 11.70 | 12,198 | 142,662 | 653,129 | 665.3 K to 653.1 K (-1.83 %) |
Oct 31 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.03 | 16,173 | 194,539 | 665,327 | 681.5 K to 665.3 K (-2.37 %) |
Oct 31 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 12.47 | 17,311 | 215,815 | 681,500 | 698.8 K to 681.5 K (-2.48 %) |
Jun 22 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 7.30 | 1,906 | 13,914 | 698,811 | 696.9 K to 698.8 K (+0.27 %) |
Jun 22 2007 | IDRA | IDERA PHARMACEUTIC ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | S | 7.38 | 1,906 | 14,060 | 696,905 | 698.8 K to 696.9 K (-0.27 %) |
Page: 1